Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study

Wim L Loosman, Marcus A Rottier, Adriaan Honig, Carl E H Siegert, Wim L Loosman, Marcus A Rottier, Adriaan Honig, Carl E H Siegert

Abstract

Background: Depressive symptoms have been reported to be associated with adverse clinical outcome in patients with chronic kidney disease (CKD) not on dialysis. This association has not been examined in Europe. Anxiety and depressive symptoms often co-occur. However, as yet there are no data concerning a possible association of anxiety symptoms with adverse clinical outcome. We examined the association of depressive and anxiety symptoms with adverse clinical outcome in Dutch CKD patients not on dialysis.

Methods: In this 3-year follow-up prospective cohort study, CKD patients not on dialysis with an estimated glomerular filtration rate (eGFR) ≤ 35 ml/min/1.73 m(2) from an urban teaching hospital were selected. Symptoms of depression and anxiety were evaluated using the Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI). Cox proportional hazards models were used to calculate hazard ratio's (HRs) with a composite event of death, initiation of dialysis, and hospitalization as outcome. HRs were adjusted for age, gender, diabetes, cardiovascular disease and eGFR.

Results: Of 100 included CKD patients depressive and anxiety symptoms were present in 34 and 31 %, respectively. Adjusted HRs for the composite event for patients with depressive and anxiety symptoms were 2.0 (95 % confidence interval (CI) 1.2-3.5) and 1.6 (95 % CI 0.9-2.7), respectively. Twenty three patients had both depressive and anxiety symptoms of whom adjusted HRs were 2.2 (95 % CI 1.2-4.0) for a composite event.

Conclusions: Depressive and anxiety symptoms are common in patients with CKD in The Netherlands. Depressive symptoms are associated with an increased risk of poor clinical outcome. Anxiety symptoms show a trend for an increased risk of poor clinical outcome. There seems to be no additive effect of anxiety symptoms in addition to depressive symptoms with regard to poor clinical outcome.

Figures

Fig. 1
Fig. 1
Kaplan-Meier survival curves for CKD patients with and without depressive or anxiety symptoms. Outcome is defined as death/dialysis or a composite event (death, dialysis or first hospitalisation)

References

    1. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188. doi: 10.1681/ASN.2004070539.
    1. Renal Data System US. USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
    1. Goldstein M, Yassa T, Dacouris N, McFarlane P. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis. 2004;44:706–714. doi: 10.1016/S0272-6386(04)00940-0.
    1. Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol. 2013;14:280. doi: 10.1186/1471-2369-14-280.
    1. Novak M, Mucsi I, Mendelssohn DC. Screening for depression: only one piece of the puzzle. Nephrol Dial Transplant. 2013;28:1336–1340. doi: 10.1093/ndt/gfs581.
    1. McKercher CM, Venn AJ, Blizzard L, Nelson MR, Palmer AJ, Ashby MA, et al. Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study. BMC Nephrol. 2013;14:83. doi: 10.1186/1471-2369-14-83.
    1. Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA. 2010;303:1946–1953. doi: 10.1001/jama.2010.619.
    1. Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84:179–191. doi: 10.1038/ki.2013.77.
    1. Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV. Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63:623–635. doi: 10.1053/j.ajkd.2013.08.024.
    1. Fan L, Sarnak MJ, Tighiouart H, Drew DA, Kantor AL, Lou KV, et al. Depression and all-cause mortality in hemodialysis patients. Am J Nephrol. 2014;40:12–18. doi: 10.1159/000363539.
    1. Balogun RA, Abdel-Rahman EM, Balogun SA, Lott EH, Lu JL, Malakauskas SM, et al. Association of depression and antidepressant use with mortality in a large cohort of patients with nondialysis-dependent CKD. Clin J Am Soc Nephrol. 2012;7:1793–1800. doi: 10.2215/CJN.02650312.
    1. Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60:54–61. doi: 10.1053/j.ajkd.2012.02.325.
    1. Ricardo AC, Fischer MJ, Peck A, Turyk M, Lash JP. Depressive symptoms and chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES) 2005–2006. Int Urol Nephrol. 2010;42:1063–1068. doi: 10.1007/s11255-010-9833-5.
    1. Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Association Between Depression and Death in People With CKD: A Meta-analysis of Cohort Studies. Am J Kidney Dis. 2013;62(3):493–505. doi: 10.1053/j.ajkd.2013.02.369.
    1. Kellerman QD, Christensen AJ, Baldwin AS, Lawton WJ. Association between depressive symptoms and mortality risk in chronic kidney disease. Health Psychol. 2010;29:594–600. doi: 10.1037/a0021235.
    1. Renal Data System US. USRDS 2013 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health: Bethesda; 2013.
    1. Stel VS, van de Luijtgaarden MW, Wanner C, Jager KJ. The 2008 ERA-EDTA Registry Annual Report-a precis. NDT Plus. 2011;4:1–13.
    1. Chiang HH, Guo HR, Livneh H, Lu MC, Yen ML, Tsai TY. Increased risk of progression to dialysis or death in CKD patients with depressive symptoms: A prospective 3-year follow-up cohort study. J Psychosom Res. 2015;79(3):228–232. doi: 10.1016/j.jpsychores.2015.01.009.
    1. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284. doi: 10.1681/ASN.2005121273.
    1. Van den Beukel TO, De Goeij MC, Dekker FW, Siegert CE, Halbesma N. Differences in progression to ESRD between black and white patients receiving predialysis care in a universal health care system. Clin J Am Soc Nephrol. 2013;8:1540–1547. doi: 10.2215/CJN.10761012.
    1. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol. 2007;18:1299–1306. doi: 10.1681/ASN.2006050524.
    1. Preljevic VT, Osthus TB, Os I, Sandvik L, Opjordsmoen S, Nordhus IH, et al. Anxiety and depressive disorders in dialysis patients: association to health-related quality of life and mortality. Gen Hosp Psychiatry. 2013;35:619–624. doi: 10.1016/j.genhosppsych.2013.05.006.
    1. Cukor D, Coplan J, Brown C, Friedman S, Newville H, Safier M, et al. Anxiety disorders in adults treated by hemodialysis: a single-center study. Am J Kidney Dis. 2008;52:128–136. doi: 10.1053/j.ajkd.2008.02.300.
    1. Bossola M, Ciciarelli C, Di SE, Conte GL, Vulpio C, Luciani G, et al. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. Gen Hosp Psychiatry. 2010;32:125–131. doi: 10.1016/j.genhosppsych.2009.10.009.
    1. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470. doi: 10.7326/0003-4819-130-6-199903160-00002.
    1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004.
    1. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897. doi: 10.1037/0022-006X.56.6.893.
    1. Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ. Validation of depression screening scales in patients with CKD. Am J Kidney Dis. 2009;54:433–439. doi: 10.1053/j.ajkd.2009.03.016.
    1. Wang MY, Chan SF, Chang LI, Chen TH, Tsai PS. Better sleep quality in chronic haemodialyzed patients is associated with morning-shift dialysis: a cross-sectional observational study. Int J Nurs Stud. 2013;50:1468–1473. doi: 10.1016/j.ijnurstu.2013.02.010.
    1. Che HH, Lu ML, Chen HC, Chang SW, Lee YJ. Validation of the Chinese version of the Beck Anxiety Inventory. Formosan Journal of Medicine. 2006;10:447–454.
    1. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343–346. doi: 10.1016/0197-2456(96)00075-X.
    1. Kop WJ, Seliger SL, Fink JC, Katz R, Odden MC, Fried LF, et al. Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Clin J Am Soc Nephrol. 2011;6:834–844. doi: 10.2215/CJN.03840510.
    1. van Dijk MR, Utens EM, Dulfer K, Al-Qezweny MN, van Geuns RJ, Daemen J et al.: (Eds):Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up. In Eur J Prev Cardiol. 2015 Feb 9. [Epub ahead of print].
    1. Safdar N, Baakza H, Kumar H, Naqvi SA. Non-compliance to diet and fluid restrictions in haemodialysis patients. J Pak Med Assoc. 1995;45:293–295.
    1. Nemeroff CB, Musselman DL. Are platelets the link between depression and ischemic heart disease? Am Heart J. 2000;140:57–62. doi: 10.1067/mhj.2000.109978.
    1. Rustad JK, Musselman DL, Nemeroff CB. The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology. 2011;36:1276–1286. doi: 10.1016/j.psyneuen.2011.03.005.
    1. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME. Circulation. 2005;111:2299–2305. doi: 10.1161/.
    1. Boulware LE, Liu Y, Fink NE, Coresh J, Ford DE, Klag MJ, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol. 2006;1:496–504. doi: 10.2215/CJN.00030505.
    1. Van WC, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol. 2004;57:672–682. doi: 10.1016/j.jclinepi.2003.12.008.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться